SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemiesynth (Vapi) informs about newspaper publication

09 Nov 2023 Evaluate
Chemiesynth (Vapi) has informed that pursuant to Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had published their Un-audited Financial Results for the Quarter/Half Year ended as on 30th September 2023 which were approved in the Board meeting held on Wednesday 08th November 2023 in one English and Gujarati language newspaper. The above advertisement was published on Thursday, 9th November, 2023. The details are as follows: (1) Indian Express-English (2) Financial Express-Gujarati.

The above information is a part of company’s filings submitted to BSE.

Chemiesynth (Vapi) Share Price

50.40 0.00 (0.00%)
08-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×